1 min read

Case Study: Good Shepherd Medical Center Awarded for Superior Stroke Care

Case Study: Good Shepherd Medical Center Awarded for Superior Stroke Care

Bozeman, MT — Pulsara is thrilled to announce that a long-time Pulsara client, Good Shepherd Medical Center (GSMC), has recently been awarded the Get with the Guidelines-Stroke Gold-Plus Quality Achievement Award in recognition of their success in implementing quality improvement measures for stroke treatment as defined by the American Heart Association and American Stroke Association. 

View/Download the Case Study

case-study-good-shepherd (1)Thanks to the superior door-to-needle times GSMC staff was able to achieve for its patients (over 75% of the hospital's stroke patients received medication within 60 minutes of arriving at the facility and more than 50% of GSMCs's stroke patients received medication in fewer than 45 minutes), the facility also received the Target Stroke Elite Plus designation. 

The aim of Get with the Guidelines-Stroke is to help hospital teams provide the latest in standards of care for their patients in efforts to reduce case times for stroke patients - which ultimately reduces hospital length of stay and reduces complications, disability and death rates after a stroke.

View/Download the Case Study

 

Pulsara Around the World - March 2026

Pulsara Around the World - March 2026

February Recap From neuroscience symposiums to EMS expos, our teams traveled to five shows in February. Our events schedule is slowing down in March....

Read More >>
Pulsara Around the World - February 2026

Pulsara Around the World - February 2026

January Recap The start of 2026 was on the slow side for our events schedule, with our team heading to the Florida Fire & EMS Conference, the...

Read More >>
Study Shows Improved Care For Rural Patients During Major Incidents With Pulsara

Study Shows Improved Care For Rural Patients During Major Incidents With Pulsara

Recent research shows how Pulsara was successfully leveraged to connect more than 6,000 COVID-19 patients to monoclonal antibody infusion centers via...

Read More >>